DR Horton Inc (DHI)
Official siteCONSUMER CYCLICAL • RESIDENTIAL CONSTRUCTION • NYSE
Market Cap: $39.51B
Last updated: Nov 17, 2026 at 11:04 AM ET
DR Horton Inc (DHI) Earnings: Report Dates and Results
DR Horton (DHI) is expected to report earnings on Jan 18, 2027. In the quarter ended Sep 30, 2026, DR Horton reported EPS of $2.67, below the $3.03 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
DHI has an expected report date of Jan 18, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 36.9% below the $2.03 reported for the quarter ended Dec 31, 2025.
DHI Earnings Call
The latest DHI earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, DHI beat 31, missed 7 and matched 2. The widest gap in the table came in the quarter ended Mar 31, 2023, when EPS landed 42.93% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $2.67 | $3.03 | $2.80 - $3.14 | -11.88% | Miss | -12.2% | 14 | 2 up, 5 down | Oct 29, 2026 | N/A |
| Jun 30, 2026 | $3.20 | $2.99 | $2.87 - $3.05 | +7.02% | Beat | -4.8% | 12 | N/A | Jul 21, 2026 | $9.23B |
| Mar 31, 2026 | $2.24 | $2.12 | $2.06 - $2.30 | +5.66% | Beat | -13.2% | 14 | 1 up, 1 down | Apr 21, 2026 | $7.56B |
| Dec 31, 2025 | $2.03 | $1.92 | $1.79 - $2.02 | +5.73% | Beat | -22.2% | 13 | 0 up, 5 down | Jan 20, 2026 | $6.89B |
| Sep 30, 2025 | $3.04 | $3.27 | $3.22 - $3.41 | -7.03% | Miss | -22.4% | 13 | 0 up, 2 down | Oct 28, 2025 | $9.68B |
| Jun 30, 2025 | $3.36 | $2.90 | $2.80 - $3.03 | +15.86% | Beat | -18.0% | 13 | 0 up, 1 down | Jul 22, 2025 | $9.23B |
| Mar 31, 2025 | $2.58 | $2.70 | $2.56 - $2.73 | -4.44% | Miss | -26.7% | 14 | 0 up, 4 down | Apr 17, 2025 | $7.73B |
| Dec 31, 2024 | $2.61 | $2.36 | $2.24 - $2.55 | +10.59% | Beat | -7.4% | 13 | 0 up, 4 down | Jan 21, 2025 | $7.61B |
| Sep 30, 2024 | $3.92 | $4.16 | $3.94 - $4.33 | -5.77% | Miss | -11.9% | 16 | 0 up, 0 down | Oct 29, 2024 | $10.00B |
| Jun 30, 2024 | $4.10 | $3.78 | $3.56 - $3.98 | +8.47% | Beat | +5.1% | 17 | 2 up, 1 down | Jul 18, 2024 | $9.97B |
| Mar 31, 2024 | $3.52 | $3.07 | $2.93 - $3.35 | +14.66% | Beat | +28.9% | 18 | 2 up, 1 down | Apr 18, 2024 | $9.11B |
| Dec 31, 2023 | $2.82 | $2.89 | $2.73 - $3.05 | -2.42% | Miss | +2.2% | 19 | 1 up, 1 down | Jan 23, 2024 | $7.73B |
| Sep 30, 2023 | $4.45 | $3.93 | $3.62 - $4.16 | +13.23% | Beat | -4.7% | 18 | 1 up, 0 down | Nov 7, 2023 | $10.50B |
| Jun 30, 2023 | $3.90 | $2.83 | $2.38 - $3.13 | +37.81% | Beat | -16.5% | 18 | 6 up, 0 down | Jul 20, 2023 | $9.73B |
| Mar 31, 2023 | $2.73 | $1.91 | $1.65 - $2.21 | +42.93% | Beat | -32.3% | 18 | 1 up, 0 down | Apr 20, 2023 | $7.97B |
| Dec 31, 2022 | $2.76 | $2.24 | $1.98 - $2.50 | +23.21% | Beat | -12.9% | 19 | 2 up, 0 down | Jan 24, 2023 | $7.26B |
| Sep 30, 2022 | $4.67 | $5.09 | $4.08 - $5.67 | -8.25% | Miss | +26.2% | 16 | 0 up, 2 down | Nov 9, 2022 | $9.64B |
| Jun 30, 2022 | $4.67 | $4.51 | $4.28 - $4.82 | +3.55% | Beat | +48.7% | 19 | 0 up, 0 down | Jul 21, 2022 | $8.79B |
| Mar 31, 2022 | $4.03 | $3.40 | $3.20 - $3.55 | +18.53% | Beat | +59.3% | 18 | 0 up, 0 down | Apr 26, 2022 | $8.00B |
| Dec 31, 2021 | $3.17 | $2.79 | $2.61 - $3.03 | +13.62% | Beat | +48.1% | 19 | N/A | Feb 2, 2022 | $7.05B |
| Sep 30, 2021 | $3.70 | $3.38 | $3.28 - $3.64 | +9.47% | Beat | +68.2% | 17 | N/A | Nov 9, 2021 | $8.11B |
| Jun 30, 2021 | $3.14 | $2.82 | $2.70 - $2.95 | +11.35% | Beat | +95.0% | 16 | N/A | Jul 22, 2021 | $7.28B |
| Mar 31, 2021 | $2.53 | $2.18 | $1.99 - $2.28 | +16.05% | Beat | +96.1% | 18 | N/A | Apr 22, 2021 | $6.45B |
| Dec 31, 2020 | $2.14 | $1.73 | $1.24 - $1.95 | +23.70% | Beat | +100.0% | 19 | N/A | Jan 26, 2021 | $5.93B |
| Sep 30, 2020 | $2.20 | $1.78 | $1.50 - $1.97 | +23.60% | Beat | +63.0% | 19 | N/A | Nov 10, 2020 | $10.42B |
| Jun 30, 2020 | $1.61 | $1.28 | $1.04 - $1.49 | +25.78% | Beat | +27.8% | 18 | N/A | Jul 28, 2020 | $5.39B |
| Mar 31, 2020 | $1.29 | $1.10 | $1.01 - $1.17 | +17.27% | Beat | +38.7% | 12 | N/A | Apr 28, 2020 | $4.50B |
| Dec 31, 2019 | $1.07 | $0.91 | $0.85 - $0.98 | +17.58% | Beat | +40.8% | 16 | N/A | Jan 27, 2020 | N/A |
| Sep 30, 2019 | $1.35 | $1.25 | $1.18 - $1.30 | +8.00% | Beat | +10.7% | 16 | N/A | Nov 12, 2019 | $5.04B |
| Jun 30, 2019 | $1.26 | $1.05 | $1.01 - $1.20 | +20.00% | Beat | +6.8% | 16 | N/A | Jul 30, 2019 | $4.91B |
| Mar 31, 2019 | $0.93 | $0.87 | $0.82 - $0.93 | +6.90% | Beat | +2.2% | 18 | N/A | Apr 25, 2019 | $4.13B |
| Dec 31, 2018 | $0.76 | $0.77 | $0.73 - $0.86 | -1.30% | Miss | +55.1% | 17 | N/A | Jan 25, 2019 | $3.52B |
| Sep 30, 2018 | $1.22 | $1.22 | $1.17 - $1.31 | 0.00% | In line | +48.8% | 17 | N/A | Nov 8, 2018 | $4.51B |
| Jun 30, 2018 | $1.18 | $1.08 | $1.02 - $1.14 | +9.26% | Beat | +55.3% | 19 | N/A | Jul 26, 2018 | $4.44B |
| Mar 31, 2018 | $0.91 | $0.86 | $0.81 - $0.91 | +5.81% | Beat | +51.7% | 20 | N/A | Apr 26, 2018 | $3.79B |
| Dec 31, 2017 | $0.49 | $0.36 | $0.29 - $0.75 | +36.11% | Beat | -10.9% | 21 | N/A | Jan 31, 2018 | $3.33B |
| Sep 30, 2017 | $0.82 | $0.82 | $0.76 - $0.88 | 0.00% | In line | +7.9% | 21 | N/A | Nov 9, 2017 | $4.16B |
| Jun 30, 2017 | $0.76 | $0.75 | $0.71 - $0.82 | +1.33% | Beat | +15.2% | 19 | N/A | Jul 26, 2017 | $3.78B |
| Mar 31, 2017 | $0.60 | $0.59 | N/A | +1.69% | Beat | +15.4% | N/A | N/A | Apr 20, 2017 | $3.25B |
| Dec 31, 2016 | $0.55 | $0.48 | N/A | +14.58% | Beat | +31.0% | N/A | N/A | Jan 24, 2017 | $2.90B |
Annual EPS
EPS for the fiscal year ended Sep 30, 2026 was $10.14, down 12.5% from the year before. It was $2.73 for the year ended Sep 30, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | $10.14 | -12.5% |
| Sep 30, 2025 | $11.59 | -19.3% |
| Sep 30, 2024 | $14.36 | +3.8% |
| Sep 30, 2023 | $13.84 | -16.3% |
| Sep 30, 2022 | $16.54 | +43.7% |
| Sep 30, 2021 | $11.51 | +86.5% |
| Sep 30, 2020 | $6.17 | +43.5% |
| Sep 30, 2019 | $4.30 | +13.2% |
| Sep 30, 2018 | $3.80 | +39.2% |
| Sep 30, 2017 | $2.73 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,600 words across 22 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,606 | 22 | |
| 2026Q2 | Jun 30, 2026 | 8,693 | 25 | |
| 2026Q1 | Mar 31, 2026 | 8,874 | 20 | |
| 2025Q4 | Dec 31, 2025 | 5,642 | 16 | |
| 2025Q3 | Sep 30, 2025 | 9,069 | 19 | |
| 2025Q2 | Jun 30, 2025 | 9,586 | 19 | |
| 2025Q1 | Mar 31, 2025 | 8,236 | 22 | |
| 2024Q4 | Dec 31, 2024 | 3,787 | 7 |
2026Q3 Earnings Call
Opening remarks
Jessica Hansen Senior Vice President, Communications Thank you, Paul. Good morning. Welcome to our call to discuss our financial results for the third quarter of fiscal 2026. Before we get started, today's call includes forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Although D.R. Horton believes any such statements are based on reasonable assumptions, there is no assurance that actual outcomes will not be materially different. All forward-looking statements are based upon information available to D.R. Horton on the date of this conference call. D.R. Horton does not undertake any obligation to publicly update or revise any forward-looking statements. Additional information about factors that could lead to material changes in performance is contained in D.R. Horton's annual report on Form 10-K and its most recent quarterly report on Form 10-Q, both of which are filed with the Securities and Exchange Commission. This morning's earnings release and our supplemental data presentation can be found on our website at investor.drhorton.com. We plan to file our 10-Q later this week. After this call, we will also post our updated investor presentation to our investor relations site on the presentation section under news and events for your reference. I will turn the call over to Paul Romanowski, our President and CEO.
Paul Romanowski President and Chief Executive Officer Thank you, Jessica. Good morning. I'm pleased to also be joined on this call by Mike Murray, our Chief Operating Officer, and Bill Wheat, our Chief Financial Officer. The D.R. Horton team delivered a solid third quarter, highlighted by earnings per diluted share of $3.20. Consolidated pre-tax income totaled $1.2 billion on $9.2 billion of revenues, resulting in a pre-tax profit margin of 13.3%. We closed 23,983 homes during the quarter, which was at the high end of our guidance range. Achieved a home sales gross margin of 20.7%. We remain focused on capital efficiency to generate strong operating cash flows and deliver compelling returns to our shareholders. Over the past 12 months, we generated $3.4 billion of cash from operations. Returned all of it to shareholders through repurchases and dividends. For the trailing 12 months and to June 30th, our home building pre-tax return on inventory was 17%, while our consolidated returns on equity and assets were 12.8% and 8.5%. Our return on assets ranks in the top 20% of all S&P 500 companies for the past three, five, and 10-year periods, demonstrating that our disciplined, returns-focused operating model delivers sustainable results and positions us well for continued value creation. We work every day to leverage our industry-leading platform, unmatched scale, efficient operations, and experienced teams to bring homeownership opportunities at affordable price points to more Americans. 65% of our mortgage company's closings this quarter were to first-time homebuyers.
Frequently Asked Questions About DHI
When is DR Horton's next earnings date?
DR Horton's next earnings report is expected for Jan 18, 2027.
Did DHI beat earnings estimates last quarter?
No. DR Horton reported EPS of $2.67 for the quarter ended Sep 30, 2026, below the $3.03 estimate by 11.88%.
What EPS do analysts expect from DHI next quarter?
The consensus EPS estimate for DR Horton for the quarter ending Dec 31, 2026 is $1.28 from 15 analysts, with estimates from $1.17 to $1.45.
How often does DHI beat earnings estimates?
DR Horton beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +2.69%.
DHI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors